SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-014634
Filing Date
2023-05-15
Accepted
2023-05-15 16:50:31
Documents
78
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sabs20230331_10q.htm   iXBRL 10-Q 1113280
2 EXHIBIT 4.1 ex_520703.htm EX-4.1 52695
3 EXHIBIT 31.1 ex_505504.htm EX-31.1 14261
4 EXHIBIT 31.2 ex_505505.htm EX-31.2 14157
5 EXHIBIT 32.1 ex_505506.htm EX-32.1 5418
6 EXHIBIT 32.2 ex_505507.htm EX-32.2 5426
  Complete submission text file 0001437749-23-014634.txt   6489367

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sabs-20230331.xsd EX-101.SCH 66593
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sabs-20230331_cal.xml EX-101.CAL 44431
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sabs-20230331_def.xml EX-101.DEF 446373
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sabs-20230331_lab.xml EX-101.LAB 391670
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sabs-20230331_pre.xml EX-101.PRE 479289
72 EXTRACTED XBRL INSTANCE DOCUMENT sabs20230331_10q_htm.xml XML 890183
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39871 | Film No.: 23923702
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences